We are Terra Lumina
advanced Drug Discovery
Rooted in Nature
Powered by ai.
Our platform is designed to uncover the therapeutic value of natural compounds to drive the next generation of small molecule drugs.
Natural compounds have been optimized by billions of years of evolution to interact with human biology.
70% of the drugs on the market today come from nature, however less than 1% of nature’s small molecules have been explored.
What if we could explore the remaining 99% at scale?
Nature offers greater chemical diversity, with better biocompatibility, efficacy and pharmacokinetic properties.
85% of the human proteome is considered “undruggable” with current available chemistry. Natural compounds offer novel chemistry with superior properties to address these targets.
77% of drugs derived from nature are related to their ethnobotanical & historical use case. Identifying the active compound in an established traditional medicine is a great way to accelerate the discovery process, reducing failure rates due to established efficacy and safety.
An integrated discovery engine
We explore nature’s biodiversity and generate data on the chemical composition of plants & other kingdoms of life, creating the most valuable screening library for therapeutic compounds ever made.
We integrate data across multiple streams to map the world’s comprehensive knowledge on plants, their chemical composition, and human biology.
We resolve the bottlenecks that historically limited natural product research, building cutting-edge technology at the intersection of machine learning, metabolomics, and cheminformatics.
Work with us to identify novel compounds, powering your early-stage discovery pipeline. We screen our rich & diverse library of natural compound scaffolds to provide high-value lead candidates for co-development.
We are building a portfolio of validated lead candidates in key therapeutic areas. Contact us to learn more about our proprietary pipeline of leads.